Literature DB >> 24266532

Mutation of nonessential cysteines shows that the NF-κB essential modulator forms a constitutive noncovalent dimer that binds IκB kinase-β with high affinity.

Shaun M Cote1, Thomas D Gilmore, Robert Shaffer, Urs Weber, Rishitha Bollam, Mary S Golden, Kimberley Glover, Melanie Herscovitch, Thomas Ennis, Karen N Allen, Adrian Whitty.   

Abstract

NEMO (NF-κB essential modulator) associates with catalytic subunits IKKα and IKKβ to form the IκB kinase (IKK) complex and is a key regulator of NF-κB pathway signaling. Biochemical and structural characterization of NEMO has been challenging, however, leading to conflicting data about basic biochemical properties such as the oligomeric state of active NEMO and its binding affinity for IKKβ. We show that up to seven of NEMO's 11 cysteine residues can be mutated to generate recombinant full-length NEMO that is highly soluble and active. Using a fluorescence anisotropy binding assay, we show that full-length NEMO binds a 44-mer peptide encompassing residues 701-745 of IKKβ with a K(D) of 2.2 ± 0.8 nM. The IKKβ binding affinities of mutants with five and seven Cys-to-Ala substitutions are indistinguishable from that of wild-type NEMO. Moreover, when expressed in NEMO -/- fibroblasts, the five-Ala and seven-Ala NEMO mutants can interact with cellular IKKβ and restore NF-κB signaling to provide protection against tumor necrosis factor α-induced cell death. Treatment of the NEMO-reconstituted cells with H₂O₂ led to the formation of covalent dimers for wild-type NEMO and the five-Ala mutant, but not for the seven-Ala mutant, confirming that Cys54 and/or Cys347 can mediate interchain disulfide bonding. However, the IKKβ binding affinity of NEMO is unaffected by the presence or absence of interchain disulfide bonding at Cys54, which lies within the IKKβ binding domain of NEMO, or at Cys347, indicating that NEMO exists as a noncovalent dimer independent of the redox state of its cysteines. This conclusion was corroborated by the observation that the secondary structure content of NEMO and its thermal stability were independent of the presence or absence of interchain disulfide bonds.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24266532      PMCID: PMC4417627          DOI: 10.1021/bi401368r

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  56 in total

Review 1.  The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling.

Authors:  M Karin; M Delhase
Journal:  Semin Immunol       Date:  2000-02       Impact factor: 11.130

2.  Determining the affinity and stoichiometry of interactions between unmodified proteins in solution using Biacore.

Authors:  Eric S Day; Allan D Capili; Christopher W Borysenko; Mohammad Zafari; Adrian Whitty
Journal:  Anal Biochem       Date:  2013-05-24       Impact factor: 3.365

3.  Crystal structure of the NEMO ubiquitin-binding domain in complex with Lys 63-linked di-ubiquitin.

Authors:  Azusa Yoshikawa; Yusuke Sato; Masami Yamashita; Hisatoshi Mimura; Atsushi Yamagata; Shuya Fukai
Journal:  FEBS Lett       Date:  2009-09-18       Impact factor: 4.124

4.  DARPin-assisted crystallography of the CC2-LZ domain of NEMO reveals a coupling between dimerization and ubiquitin binding.

Authors:  Olivera Grubisha; Monika Kaminska; Stéphane Duquerroy; Elisabeth Fontan; Florence Cordier; Ahmed Haouz; Bertrand Raynal; Jeanne Chiaravalli; Muriel Delepierre; Alain Israël; Michel Véron; Fabrice Agou
Journal:  J Mol Biol       Date:  2009-10-23       Impact factor: 5.469

5.  A homogeneous time-resolved fluorescence-based high-throughput screening system for discovery of inhibitors of IKKbeta-NEMO interaction.

Authors:  Yusuke Gotoh; Hidetaka Nagata; Hideo Kase; Manabu Shimonishi; Motoharu Ido
Journal:  Anal Biochem       Date:  2010-06-01       Impact factor: 3.365

6.  Oligomeric state of wild-type and cysteine-less yeast mitochondrial citrate transport proteins.

Authors:  R Kotaria; J A Mayor; D E Walters; R S Kaplan
Journal:  J Bioenerg Biomembr       Date:  1999-12       Impact factor: 2.945

7.  Impediment of NEMO oligomerization inhibits osteoclastogenesis and osteolysis.

Authors:  Isra Darwech; Jesse Otero; Muhammad Alhawagri; Simon Dai; Yousef Abu-Amer
Journal:  J Cell Biochem       Date:  2009-12-15       Impact factor: 4.429

8.  Structural basis for recognition of diubiquitins by NEMO.

Authors:  Yu-Chih Lo; Su-Chang Lin; Carla C Rospigliosi; Dietrich B Conze; Chuan-Jin Wu; Jonathan D Ashwell; David Eliezer; Hao Wu
Journal:  Mol Cell       Date:  2009-01-29       Impact factor: 17.970

9.  Novel insights into the cellular mechanisms of the anti-inflammatory effects of NF-kappaB essential modulator binding domain peptides.

Authors:  Eric T Baima; Julia A Guzova; Sumathy Mathialagan; Eva E Nagiec; Medora M Hardy; Lily R Song; Sheri L Bonar; Robin A Weinberg; Shaun R Selness; Scott S Woodard; Jill Chrencik; William F Hood; John F Schindler; Nandini Kishore; Gabriel Mbalaviele
Journal:  J Biol Chem       Date:  2010-02-18       Impact factor: 5.157

10.  NEMO oligomerization and its ubiquitin-binding properties.

Authors:  Frank J Ivins; Mark G Montgomery; Susan J M Smith; Aylin C Morris-Davies; Ian A Taylor; Katrin Rittinger
Journal:  Biochem J       Date:  2009-06-26       Impact factor: 3.857

View more
  8 in total

1.  A Central Region of NF-κB Essential Modulator Is Required for IKKβ-Induced Conformational Change and for Signal Propagation.

Authors:  Robert Shaffer; Anthony M DeMaria; Larisa Kagermazova; Yuekun Liu; Milad Babaei; Suhaily Caban-Penix; Arisdelsy Cervantes; Stefan Jehle; Lee Makowski; Thomas D Gilmore; Adrian Whitty; Karen N Allen
Journal:  Biochemistry       Date:  2019-06-18       Impact factor: 3.321

2.  Disulfide-mediated stabilization of the IκB kinase binding domain of NF-κB essential modulator (NEMO).

Authors:  Li Zhou; Alan T Yeo; Carmine Ballarano; Urs Weber; Karen N Allen; Thomas D Gilmore; Adrian Whitty
Journal:  Biochemistry       Date:  2014-12-08       Impact factor: 3.162

3.  Quantification of cellular NEMO content and its impact on NF-κB activation by genotoxic stress.

Authors:  Byounghoon Hwang; Funita P Phan; Kevin McCool; Eun Young Choi; Jinsam You; Adam Johnson; Anjon Audhya; Shigeki Miyamoto
Journal:  PLoS One       Date:  2015-03-05       Impact factor: 3.240

4.  Mutation of cysteine 46 in IKK-beta increases inflammatory responses.

Authors:  Ting Li; Vincent Kam Wai Wong; Zhi Hong Jiang; Shui Ping Jiang; Yan Liu; Ting Yu Wang; Xiao Jun Yao; Xiao Hui Su; Feng Gen Yan; Juan Liu; Elaine Lai-Han Leung; Xiao Qin Yi; Yuen Fan Wong; Hua Zhou; Liang Liu
Journal:  Oncotarget       Date:  2015-10-13

5.  Development of novel NEMO-binding domain mimetics for inhibiting IKK/NF-κB activation.

Authors:  Jing Zhao; Lei Zhang; Xiaodong Mu; Christelle Doebelin; William Nguyen; Callen Wallace; Daniel P Reay; Sara J McGowan; Lana Corbo; Paula R Clemens; Gabriela Mustata Wilson; Simon C Watkins; Laura A Solt; Michael D Cameron; Johnny Huard; Laura J Niedernhofer; Theodore M Kamenecka; Paul D Robbins
Journal:  PLoS Biol       Date:  2018-06-11       Impact factor: 8.029

6.  The IKK-binding domain of NEMO is an irregular coiled coil with a dynamic binding interface.

Authors:  Adam H Barczewski; Michael J Ragusa; Dale F Mierke; Maria Pellegrini
Journal:  Sci Rep       Date:  2019-02-27       Impact factor: 4.379

7.  CRISPR/Cas9-based editing of a sensitive transcriptional regulatory element to achieve cell type-specific knockdown of the NEMO scaffold protein.

Authors:  Milad Babaei; Yuekun Liu; Shelly M Wuerzberger-Davis; Ethan Z McCaslin; Christopher J DiRusso; Alan T Yeo; Larisa Kagermazova; Shigeki Miyamoto; Thomas D Gilmore
Journal:  PLoS One       Date:  2019-09-25       Impact factor: 3.240

8.  Protein engineering of the N-terminus of NEMO: structure stabilization and rescue of IKKβ binding.

Authors:  Bingqian Guo; Christopher O Audu; Jared C Cochran; Dale F Mierke; Maria Pellegrini
Journal:  Biochemistry       Date:  2014-10-23       Impact factor: 3.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.